{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:40:04Z","timestamp":1760269204104,"version":"build-2065373602"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Care Nursing Clinics of North America"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ccell.2014.02.004","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T17:29:25Z","timestamp":1395422965000},"page":"277-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Nutrition as Medical Therapy"],"prefix":"10.1016","volume":"26","author":[{"given":"Dinesh","family":"Yogaratnam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britney","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"DiNapoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2014.02.004_bib1","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(11)61452-9","article-title":"Selenium and human health","volume":"379","author":"Rayman","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ccell.2014.02.004_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(00)02490-9","article-title":"The importance of selenium to human health","volume":"356","author":"Rayman","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ccell.2014.02.004_bib3","doi-asserted-by":"crossref","first-page":"d1542","DOI":"10.1136\/bmj.d1542","article-title":"Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients","volume":"342","author":"Andrews","year":"2011","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ccell.2014.02.004_bib4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/01.CCM.0000251124.83436.0E","article-title":"Selenium in intensive care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock","volume":"35","author":"Angstwurm","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ccell.2014.02.004_bib5","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1007\/s00134-011-2212-6","article-title":"High dose selenium reduces ventilator-associated pneumonia and illness severity in critically ill patients with systemic inflammation","volume":"37","author":"Manzanares","year":"2011","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ccell.2014.02.004_bib6","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ccell.2014.02.004_bib7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/CCM.0b013e31827e83af","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012","volume":"41","author":"Dellinger","year":"2013","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccell.2014.02.004_bib8","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1186\/cc5960","article-title":"Effects of high dose selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind phase II study","volume":"11","author":"Forceville","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.ccell.2014.02.004_bib9","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1212722","article-title":"A\u00a0randomized trial of glutamine and antioxidants in critically ill patients","volume":"368","author":"Heyland","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccell.2014.02.004_bib10","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1097\/CCM.0b013e31829106e5","article-title":"The effect of selenium therapy on mortality in patients with sepsis syndrome: simple selenium supplementation or real (5H2O)\u2022Na2SeO3 pharmacological effect?","volume":"41","author":"Forceville","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ccell.2014.02.004_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/cc5975","article-title":"Selenium supplementation in critically ill patients: can too much of a good thing be a bad thing?","volume":"11","author":"Heyland","year":"2007","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.ccell.2014.02.004_bib12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/SHK.0b013e318193c35d","article-title":"A\u00a0large bolus injection, but not continuous infusion of sodium selenite improves outcome in peritonitis","volume":"32","author":"Wang","year":"2009","journal-title":"Shock"},{"issue":"6","key":"10.1016\/j.ccell.2014.02.004_bib13","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/CCM.0b013e31828a24c6","article-title":"The effect of selenium therapy on mortality in patients with sepsis syndrome: a systemic review and meta-analysis of randomized controlled trials","volume":"41","author":"Alhazzani","year":"2013","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.ccell.2014.02.004_bib14","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.ajem.2013.04.020","article-title":"Selenium supplementation for sepsis: a meta-analysis of randomized controlled trials","volume":"31","author":"Kong","year":"2013","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ccell.2014.02.004_bib15","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/00000542-199804000-00028","article-title":"Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats","volume":"88","author":"Weinberg","year":"1998","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ccell.2014.02.004_bib16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.rapm.2005.02.011","article-title":"Lipid infusion accelerates removal of bupivacaine and recovery from bupivacaine toxicity in the isolated rat heart","volume":"31","author":"Weinberg","year":"2006","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.ccell.2014.02.004_bib17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00000542-200607000-00033","article-title":"Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest","volume":"105","author":"Rosenblatt","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ccell.2014.02.004_bib18","first-page":"800","article-title":"Successful resuscitation of a patient with ropivacaine-induced asystole after axillary plexus block using lipid infusion","volume":"61","author":"Litz","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ccell.2014.02.004_bib19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.resuscitation.2009.01.023","article-title":"Intravenous fat emulsion therapy for intentional sustained-release verapamil overdose","volume":"80","author":"Young","year":"2009","journal-title":"Resuscitation"},{"key":"10.1016\/j.ccell.2014.02.004_bib20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.annemergmed.2006.07.016","article-title":"Intralipid outperforms sodium bicarbonate in a rabbit model of clomipramine toxicity","volume":"49","author":"Harvey","year":"2007","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ccell.2014.02.004_bib21","first-page":"465","article-title":"Lipid rescue for tricyclic antidepressant cardiotoxicity","volume":"43","author":"Blaber","year":"2012","journal-title":"Emerg Med"},{"key":"10.1016\/j.ccell.2014.02.004_bib22","first-page":"1","article-title":"Case report: successful lipid resuscitation in multi-drug overdose with predominant tricyclic antidepressant toxidrome","volume":"5","author":"Harvery","year":"2012","journal-title":"Int J Emerg Med"},{"key":"10.1016\/j.ccell.2014.02.004_bib23","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3109\/15563650.2011.583251","article-title":"Severe propranolol and ethanol overdose with wide complex tachycardia treated with intravenous lipid emulsion: a case report","volume":"49","author":"Jovic-Stosic","year":"2011","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.ccell.2014.02.004_bib24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2044.2008.05744.x","article-title":"Early treatment of a quetiapine and sertraline overdose with intralipid","volume":"64","author":"Finn","year":"2009","journal-title":"Anaesthesia"},{"key":"10.1016\/j.ccell.2014.02.004_bib25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jemermed.2010.11.055","article-title":"Lipid emulsion as rescue therapy in lamotrigine overdose","volume":"42","author":"Castanares-Zapatero","year":"2012","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.ccell.2014.02.004_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s13181-010-0125-3","article-title":"ACMT position statement: interim guidance for the use of lipid rescue therapy","volume":"7","author":"American College of Medical Toxicology","year":"2011","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.ccell.2014.02.004_bib27","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.ajem.2013.03.010","article-title":"Lipid emulsion therapy in cardiodepressive syndrome after diltiazem overdose \u2013 case report","volume":"31","author":"Bologa","year":"2013","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ccell.2014.02.004_bib28","series-title":"Goodman & Gilman's the pharmacological basis of therapeutics","article-title":"Chapter 43. Endocrine pancreas and pharmacotherapy of diabetes mellitus and hypoglycemia","author":"Powers","year":"2011"},{"key":"10.1016\/j.ccell.2014.02.004_bib29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ajem.2005.05.001","article-title":"2004 Annual report of the American Association of poison control centers toxic exposure surveillance system","volume":"23","author":"Watson","year":"2005","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ccell.2014.02.004_bib30","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.2146\/ajhp060041","article-title":"Treatment of poisoning caused by \u03b2-adrenergic and calcium channel blockers","volume":"63","author":"Shepherd","year":"2006","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"10.1016\/j.ccell.2014.02.004_bib31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/cc4938","article-title":"Bench-to-bedside review: hyperinsulinemia\/euglycemia therapy in the management of overdose of calcium-channel blockers","volume":"10","author":"Lheureux","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.ccell.2014.02.004_bib32","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1056\/NEJMcpc069016","article-title":"Case 24-2006: a 40-year-old woman with hypotension after an overdose of amlodipine","volume":"355","author":"Harris","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccell.2014.02.004_bib33","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/emj.2009.077347","article-title":"Diltiazem overdose: a role for high-dose insulin","volume":"27","author":"Abeysinghe","year":"2010","journal-title":"Emerg Med J"},{"key":"10.1016\/j.ccell.2014.02.004_bib34","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3109\/15563650.2011.593522","article-title":"High-dose insulin: a consecutive case series in toxin-induced cardiogenic shock","volume":"49","author":"Holger","year":"2011","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.ccell.2014.02.004_bib35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/15563650.2011.582471","article-title":"High-dose insulin therapy in beta-blocker and calcium-channel blocker poisoning","volume":"49","author":"Engebretsen","year":"2011","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.ccell.2014.02.004_bib36","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00134-007-0768-y","article-title":"Relative safety of hyperinsulinemia\/euglycemia therapy in the management of calcium channel blocker overdose: a prospective observational study","volume":"33","author":"Green","year":"2007","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ccell.2014.02.004_bib37","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1345\/aph.1E436","article-title":"High-dose insulin therapy for calcium-channel blocker overdose","volume":"39","author":"Shepherd","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.ccell.2014.02.004_bib38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF03160923","article-title":"The use of carnitine for the management of acute valproic acid toxicity","volume":"3","author":"Katiyar","year":"2007","journal-title":"J\u00a0Med Toxicol"},{"issue":"1","key":"10.1016\/j.ccell.2014.02.004_bib39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.yrtph.2006.06.007","article-title":"Risk assessment for carnitine","volume":"46","author":"Hathcock","year":"2006","journal-title":"Regul Toxicol Pharmacol"},{"year":"2006","series-title":"Goldfrank\u2019s toxicological emergencies","author":"Flomenbaum","key":"10.1016\/j.ccell.2014.02.004_bib40"},{"key":"10.1016\/j.ccell.2014.02.004_bib41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/15563650902752376","article-title":"Carnitine in the treatment of valproic acid-induced toxicity","volume":"47","author":"Lheureux","year":"2009","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.ccell.2014.02.004_bib42","unstructured":"Levocarnitine [package insert]. Gaithersburg, MD: Sigma-Tau Pharmaceuticals, Inc. 2004."},{"key":"10.1016\/j.ccell.2014.02.004_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2146\/ajhp110049","article-title":"Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy","volume":"69","author":"Mock","year":"2012","journal-title":"Am J Health Syst Pharm"},{"issue":"5","key":"10.1016\/j.ccell.2014.02.004_bib44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/cc3742","article-title":"Carnitine in the treatment of valproic acid-induced toxicity \u2013 what is the evidence?","volume":"9","author":"Lheureux","year":"2005","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccell.2014.02.004_bib45","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0026-0495(99)90013-6","article-title":"Effect of long-term valproic acid administration on the efficiency of carnitine reabsorption in humans","volume":"48","author":"Stadler","year":"1999","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.ccell.2014.02.004_bib46","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1081\/CLT-120014645","article-title":"Valproic acid toxicity: overview and management","volume":"40","author":"Sztajnkrycer","year":"2002","journal-title":"J\u00a0Toxicol Clin Toxicol"},{"issue":"11","key":"10.1016\/j.ccell.2014.02.004_bib47","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1528-1157.1998.tb01315.x","article-title":"L-carnitine supplementation in childhood epilepsy: current perspectives","volume":"39","author":"DeVivo","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.ccell.2014.02.004_bib48","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0022-3476(05)81711-1","article-title":"Hepatotoxic effects in a child receiving valproate and carnitine","volume":"123","author":"Murphy","year":"1993","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ccell.2014.02.004_bib49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jat\/20.1.55","article-title":"Valproic acid overdose and l-carnitine therapy","volume":"20","author":"Ishikura","year":"1996","journal-title":"J\u00a0Anal Toxicol"},{"key":"10.1016\/j.ccell.2014.02.004_bib50","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1471-4159.1994.62031137.x","article-title":"Valproate increases glutaminase and decreases glutamine synthetase activities in primary cultures of rat brain astrocytes","volume":"62","author":"Collins","year":"1994","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.ccell.2014.02.004_bib51","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-2999(83)90327-8","article-title":"Sodium valproate-induced hyperammonemia in the rat: role of the kidney","volume":"87","author":"Warter","year":"1983","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1016\/j.ccell.2014.02.004_bib52","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1528-1157.1996.tb00634.x","article-title":"Effect of l-carnitine supplementation on acute valproate intoxication","volume":"37","author":"Murakami","year":"1996","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.ccell.2014.02.004_bib53","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0022-3476(82)80320-X","article-title":"Carnitine deficiency and hyperammonemia associated with valproic acid therapy","volume":"101","author":"Ohtani","year":"1982","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ccell.2014.02.004_bib54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00330-004-2338-9","article-title":"Comparison of clinical, magnetic resonance and evoked potentials data in a case of valproic-acid-related hyperammonemic coma","volume":"15","author":"Hantson","year":"2005","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ccell.2014.02.004_bib55","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1212\/WNL.56.10.1405","article-title":"Effect of l-carnitine treatment for valproate-induced hepatotoxicity","volume":"56","author":"Bohan","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ccell.2014.02.004_bib56","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ajem.2005.02.015","article-title":"L-carnitine was safely administered in the setting of valproate toxicity","volume":"23","author":"LoVecchio","year":"2005","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ccell.2014.02.004_bib57","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1345\/aph.1P135","article-title":"L-carnitine for acute valproic acid overdose: a systematic review of published cases","volume":"44","author":"Perrott","year":"2010","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1016\/j.ccell.2014.02.004_bib58","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1345\/aph.19242","article-title":"The role of carnitine supplementation during valproic acid therapy","volume":"34","author":"Raskind","year":"2000","journal-title":"Ann Pharmacother"}],"container-title":["Critical Care Nursing Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899588514000100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899588514000100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:27:52Z","timestamp":1760268472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899588514000100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0899588514000100"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2014.02.004","relation":{},"ISSN":["0899-5885"],"issn-type":[{"type":"print","value":"0899-5885"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutrition as Medical Therapy","name":"articletitle","label":"Article Title"},{"value":"Critical Care Nursing Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2014.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}